Published in Infection on October 23, 1985
Effect of broad-spectrum parenteral antibiotics on composition of intestinal microflora of humans. Antimicrob Agents Chemother (1987) 1.47
Effect of antibiotic treatment on growth of and toxin production by Clostridium difficile in the cecal contents of mice. Antimicrob Agents Chemother (2005) 1.40
Effects of broad-spectrum antimicrobial agents on yeast colonization of the gastrointestinal tracts of mice. Antimicrob Agents Chemother (1990) 1.20
Prospective evaluation of effects of broad-spectrum antibiotics on gastrointestinal yeast colonization of humans. Antimicrob Agents Chemother (1993) 1.18
Modulation of the intestinal flora of mice by treatment with aztreonam and tigemonam. Antimicrob Agents Chemother (1991) 0.79
Evaluation of five test-kits-API, AuxoTab, Enterotube, PathoTec and R-B-for identification of Enterobacteriaceae. Med Microbiol Immunol (1974) 8.61
Formation of beta-lactamase in Bacteroides fragilis: cell-bound and extracellular activity. Antimicrob Agents Chemother (1976) 4.64
Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis (2001) 4.17
Antibiotic susceptibility of anaerobic bacteria with special reference to Bacteroides fragilis. Scand J Infect Dis Suppl (1979) 2.66
Acute appendicitis: a clinical study of 1018 cases of emergency appendectomy. Acta Chir Scand (1982) 2.65
Neonatal infections caused by group B streptococci. Scand J Infect Dis (1971) 2.49
Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother (2001) 2.35
Evaluation of two test-kits--API and Oxi Ferm tube--for identification of oxidative-fermentative Gram-negative rods. Med Microbiol Immunol (1977) 2.31
Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982. J Infect Dis (1985) 2.16
Factors contributing to resistance to beta-lactam antibiotics in Bacteroides fragilis. Antimicrob Agents Chemother (1979) 2.15
Immunochemical fingerprinting of Clostridium difficile strains isolated from an outbreak of antibiotic-associated colitis and diarrhoea. J Med Microbiol (1984) 2.07
Effect of vancomycin on intestinal flora of patients who previously received antimicrobial therapy. Clin Infect Dis (1997) 2.02
Antibacterial activity of new beta-lactam antibiotics on cefoxitin-resistant strains of Bacteroides fragilis. J Antimicrob Chemother (1980) 1.95
Prophylactic administration of penicillins for endocarditis does not reduce the incidence of postextraction bacteremia. Clin Infect Dis (1993) 1.92
Evaluation of a micromethod for determination of antibiotic concentrations in plasma. Eur J Clin Pharmacol (1972) 1.79
In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia. Antimicrob Agents Chemother (2001) 1.74
Obstruction of appendix vermiformis causing acute appendicitis. An experimental study in the rabbit. Acta Chir Scand (1982) 1.67
Rapid grouping of streptococci by immunoelectroosmophoresis. Med Microbiol Immunol (1974) 1.67
Development of the faecal anaerobic microflora after caesarean section and treatment with antibiotics in newborn infants. Infection (1987) 1.66
Ceftriaxone: renal and biliary excretion and effect on the colon microflora. J Antimicrob Chemother (1982) 1.65
Factors controlling the bacterial colonization of the intestine in breastfed infants. Acta Paediatr Suppl (1999) 1.62
Pulmonary densities during anesthesia with muscular relaxation--a proposal of atelectasis. Anesthesiology (1985) 1.61
Effect of phenoxymethylpenicillin and clindamycin on the oral, throat and faecal microflora of man. Scand J Infect Dis (1979) 1.61
Biochemical characterization and in vitro determination of antibiotic susceptibility of clinical isolates of Bacteroides fragilis. Scand J Infect Dis (1974) 1.57
The composition of the faecal microflora in breastfed and bottle fed infants from birth to eight weeks. Acta Paediatr Scand (1985) 1.56
Susceptibility to beta-lactam antibiotics and production of beta-lactamase in Bacteroides fragilis. Med Microbiol Immunol (1977) 1.55
Antibiotic susceptibility testing of anaerobic bacteria by the standardized disc diffusion method with special reference to bacteroides fragilis. Scand J Infect Dis (1975) 1.54
Aspects on antibacterial treatment of anaerobic infections. Scand J Infect Dis Suppl (1982) 1.53
A 5-year follow-up study of 117 battered women. Am J Public Health (1991) 1.53
Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients. J Antimicrob Chemother (1999) 1.52
Beta-lactamase-producing Bacteroides species in the oral cavity in relation to penicillin therapy. J Antimicrob Chemother (1981) 1.52
Utilisation of medical care by abused women. BMJ (1992) 1.52
Imipenem/cilastatin, an alternative treatment of pseudomonas infection in cystic fibrosis. J Antimicrob Chemother (1988) 1.48
Differences at the receptor and postreceptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis. Diabetes (1983) 1.48
In vitro effect of metronidazole and tinidazole on anaerobic bacteria. Med Microbiol Immunol (1974) 1.47
Probiotics and gastrointestinal diseases. J Intern Med (2005) 1.47
Chronic meningitis caused by a penicillin-sensitive microorganism? Lancet (1983) 1.46
Characterization of three different beta-lactamases from the Bacteroides fragilis group. Antimicrob Agents Chemother (1980) 1.45
Pharmacokinetics and tissue penetration of tazobactam and piperacillin in patients undergoing colorectal surgery. Antimicrob Agents Chemother (1992) 1.45
The terrorist bomb explosion in Bologna, Italy, 1980: an analysis of the effects and injuries sustained. J Trauma (1982) 1.41
Prolonged and profound acid inhibition is crucial in Helicobacter pylori treatment with a proton pump inhibitor combined with amoxicillin. Scand J Gastroenterol (1998) 1.40
Ecological effects of linezolid versus amoxicillin/clavulanic acid on the normal intestinal microflora. Scand J Infect Dis (2001) 1.37
Lung collapse and gas exchange during general anesthesia: effects of spontaneous breathing, muscle paralysis, and positive end-expiratory pressure. Anesthesiology (1987) 1.37
Resistance to beta-lactam antibiotics in Bacteroides species. J Antimicrob Chemother (1981) 1.36
Synergistic effect of combinations of sulfamethoxazole, trimethoprim, and colistin against Pseudomonas maltophilia and Pseudomonas cepacia. Antimicrob Agents Chemother (1974) 1.35
Regional differences in the control of lipolysis in human adipose tissue. Metabolism (1979) 1.35
Impact of antimicrobial agents on the gastrointestinal microflora and the risk of infections. Am J Med (1984) 1.34
The normal human anaerobic microflora. Scand J Infect Dis Suppl (1982) 1.33
Detection and quantitation by lysis-filtration of bacteremia after different oral surgical procedures. J Clin Microbiol (1990) 1.32
Home intravenous antibiotic treatment of patients with cystic fibrosis. Acta Paediatr (1992) 1.31
In-vitro susceptibility of anaerobic bacteria to GAR-936, a new glycylcycline. Clin Microbiol Infect (2000) 1.31
Distinct ribotypes and rates of antimicrobial drug resistance in Clostridium difficile from Shanghai and Stockholm. Clin Microbiol Infect (2009) 1.31
In vitro sensitivity of isolates of Pseudomonas aeruginosa to carbenicillin, gentamicin, tobramycin, and some other antibiotics. Scand J Infect Dis (1974) 1.29
Fecal bacterial microflora of newborn infants during intensive care management and treatment with five antibiotic regimens. Pediatr Infect Dis (1986) 1.28
Numerical taxonomy and laboratory identification of Actinomyces and Arachnia and some related bacteria. J Gen Microbiol (1975) 1.27
Comparative effects of moxifloxacin and clarithromycin on the normal intestinal microflora. Scand J Infect Dis (2000) 1.27
Serological studies of Actinomyces israelii by crossed immunoelectrophoresis: taxonomic and diagnostic applications. Infect Immun (1975) 1.27
Isolation of beta-lactamase-producing Bacteroides strains associated with clinical failures with penicillin treatment of human orofacial infections. Arch Oral Biol (1980) 1.26
Effect of cefoperazone on faecal flora. J Antimicrob Chemother (1983) 1.26
Comparative in vitro activity of the new oral penem ALP-201 against aerobic and anaerobic bacteria. Eur J Clin Microbiol Infect Dis (1989) 1.26
Norfloxacin binds to human fecal material. Antimicrob Agents Chemother (1988) 1.25
The role of Bacteroides fragilis in the pathogenesis of acute appendicitis. Acta Chir Scand (1982) 1.25
Antibiotic susceptibility of Clostridium species isolated from human infections. Scand J Infect Dis (1975) 1.25
Morphine glucuronidation in human fetal and adult liver. Eur J Clin Pharmacol (1982) 1.24
Oral morphine in cancer patients: in vivo kinetics and in vitro hepatic glucuronidation. Br J Clin Pharmacol (1985) 1.23
Characterization of three Aeromonas and nine pseudomonas species by extracellular enzymes and haemolysins. Med Microbiol Immunol (1975) 1.22
European surveillance study on the antibiotic susceptibility of Propionibacterium acnes. Clin Microbiol Infect (2005) 1.22
Pharmacokinetics of ciprofloxacin and effect of repeated dosage on salivary and fecal microflora. Antimicrob Agents Chemother (1986) 1.20
Imipenem/cilastatin in the treatment of intraabdominal infections: a review of worldwide experience. Rev Infect Dis (1985) 1.20
Bacterial colonisation with Xanthomonas maltophilia--a retrospective study in a cystic fibrosis patient population. Infection (1995) 1.19
Serum antibody response to Clostridium difficile toxins in patients with Clostridium difficile diarrhoea. Infection (1985) 1.18
The urgency of care need and patient satisfaction at a hospital emergency department. Health Care Manage Rev (1992) 1.18
Production of phospholipase C (alpha-toxin), haemolysins and lethal toxins by Clostridium perfringens types A to D. J Gen Microbiol (1976) 1.17
Comparative in vitro activity of BAY 12-8039 and five other antimicrobial agents against anaerobic bacteria. Eur J Clin Microbiol Infect Dis (1998) 1.16
Atelectasis and lung function in the postoperative period. Acta Anaesthesiol Scand (1992) 1.16
In vitro activity of HMR 3647 against anaerobic bacteria. J Chemother (1998) 1.16
Some properties of coagulase-negative deoxyribonuclease-producing strains of staphylococci from human infections. Med Microbiol Immunol (1976) 1.16
Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe. Clin Microbiol Infect (2003) 1.16
Ligature wires and elastomeric rings: two methods of ligation, and their association with microbial colonization of Streptococcus mutans and lactobacilli. Eur J Orthod (1991) 1.16
Purification and properties of a novel beta-lactamase from Fusobacterium nucleatum. Antimicrob Agents Chemother (1985) 1.15
Anaerobic bacteria in late infections following orthopedic surgery. Med Microbiol Immunol (1979) 1.15
Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections. Antimicrob Agents Chemother (1992) 1.15
Formation of phospholipase C and theta-haemolysin in pre-reduced media in batch anc continuous culture of Clostridium perfringens type A. J Gen Microbiol (1974) 1.14
Purification and characterization of an imipenem hydrolysing metallo-beta-lactamase from Bacteroides fragilis. J Antimicrob Chemother (1992) 1.14
Concentrations of ampicillin plus sulbactam in serum and intestinal mucosa and effects on the colonic microflora in patients undergoing colorectal surgery. Eur J Clin Microbiol (1983) 1.13
Chromosomal regions involved in the pathogenesis of osteosarcomas. Genes Chromosomes Cancer (2000) 1.13
Effect of quinolones on intestinal ecology. Drugs (1999) 1.13
Postoperative lymphoedema after treatment of breast cancer. Acta Chir Scand (1983) 1.13
Prognostic impact of chromosomal aberrations in Ewing tumours. Br J Cancer (2002) 1.13